Glucose Health, Inc.
Close on Oct 19, 2026
- Market cap
- $1.82M
- P/E (TTM)
- –
- Dividend yield
- –
About Glucose Health
Medicinal Chemicals & Botanical Products, SIC 2833
Glucose Health, Inc. manufactures dietary supplements designed to support healthy blood sugar, triglyceride, and cholesterol levels, as well as promote digestive health. Its primary offering is Glucose Health®, a dietary supplement formulated with soluble fiber and plant-based extracts. The company targets consumer markets concerned with pre-diabetes and Type-2 diabetes. It distributes its products primarily through national and regional pharmacy retailers, while also offering direct sales to consumers via dedicated websites and online marketplaces.
The company operates without full-time employees, relying instead on consultants and third-party contractors for product compounding, testing, warehousing, and order fulfillment. Its principal dietary supplement product is stocked in Walmart pharmacy locations across all 50 U.S. states. Contracted production and fulfillment operations take place at facilities located in Gravette, Arkansas. Glucose Health, Inc. maintains its corporate headquarters in Bentonville, Arkansas.
Summary of the business section of Glucose Health's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Glucose Health, Inc.
- Founded
- 2007
- Headquarters
- Bentonville, AR
- Address
- 609 Sw 8th Street, Suite 600 72712
- Phone
- (479) 802-3827
- Website
- glucosehealthinc.com
- Employees
- 3, Dec 31, 2014
- Industry
- Medicinal Chemicals & Botanical Products
- Incorporated in
- Delaware
- Fiscal year ends
- December 31
Stock & identifiers
- Ticker
- GLUC
- Exchange
- OTC
- Shares outstanding
- 5M, Nov 14, 2017
- Public float
- $78.49K, Jun 30, 2016
- Filer category
- Smaller reporting company
- Stock splits
- 1-for-50 reverse, Mar 30, 2015; 1-for-50 reverse, Nov 17, 2014; 1-for-10 reverse, Jun 25, 2014; 1-for-10 reverse, Feb 26, 2014; 6-for-5, Jun 25, 2010
- SEC CIK
- 1420108
- EIN
- 90-1117742
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
Glucose Health's leadership is listed in its proxy statement (Form DEF 14A).
Employees
Headcount reported in annual reports
“We have three employees.”
Corporate history
Events identified from SEC filings